MPM ASSET MANAGEMENT LLC's Net Worth

$104 Million

Estimate Recalculated Mar 11, 2024 04:32PM EST

Who is MPM ASSET MANAGEMENT LLC?

MPM ASSET MANAGEMENT LLC has an estimated net worth of $104 Million. This is based on reported shares across multiple companies, which include SONIC INNOVATIONS INC, Harpoon Therapeutics, Inc., TCR2 THERAPEUTICS INC., Oncorus, Inc., Zalicus Inc., and IDENIX PHARMACEUTICALS INC.

SEC CIK

MPM ASSET MANAGEMENT LLC's CIK is 0001263048

Past Insider Trading and Trends

2019 was MPM ASSET MANAGEMENT LLC's most active year for acquiring shares with 8 total transactions. MPM ASSET MANAGEMENT LLC's most active month to acquire stocks was the month of January. 2021 was MPM ASSET MANAGEMENT LLC's most active year for disposing of shares, totalling 26 transactions. MPM ASSET MANAGEMENT LLC's most active month to dispose stocks was the month of September. 2019 saw MPM ASSET MANAGEMENT LLC paying a total of $14,121,250.25 for 8,058,849 shares, this is the most they've acquired in one year. In 2021 MPM ASSET MANAGEMENT LLC cashed out on 1,303,581 shares for a total of $24,300,362.24, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Harpoon Therapeutics, Inc. (HARP) Snapshot price: $22.33

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.14%
-4.67K
$20.16
-$94,075.07
3.22M
Scheduled
Apr 13 - Apr 15
Form 4
-0.40%
-12.80K
$23.15
-$296,261.00
3.23M
Scheduled
Apr 9 - Apr 12
Form 4
-5.35%
-183.05K
$20.00
-$3,661,020.00
3.24M
Scheduled
Feb 10
Form 4
-2.61%
-91.70K
$20.06
-$1,839,336.84
3.42M
Scheduled
Feb 5 - Feb 9
Form 4
-3.30%
-120.07K
$20.22
-$2,427,558.45
3.51M
Scheduled
Feb 2 - Feb 4
Form 4
-16.56%
-721.19K
$20.02
-$14,441,349.42
3.63M
Scheduled
Jan 25 - Jan 27
Form 4
-3.76%
-170.10K
$22.51
—
4.35M
Scheduled
Jan 20 - Jan 22
Form 4
+1,304.83%
4.2M
$9.58
-$21,336.00
4.52M
Feb 12
Form 3
—
0
—
—
0
No matching records found

TCR2 THERAPEUTICS INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-4.16M
—
—
0
Jun 1
Form 4
+55.18%
108.1K
$1.31
-$0.54
304K
May 22
Form 4
+1,967.80%
3.85M
$15.00
—
4.05M
Feb 19
Form 3
—
0
—
—
0
No matching records found

IDENIX PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-9.58%
-508.37K
$14.00
-$7,117,194.00
4.8M
Jul 27
Form 3
—
0
—
—
0
No matching records found

SONIC INNOVATIONS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.50%
-30.00K
$7.12
-$213,515.00
1.97M
Oct 29 - Oct 30
Form 4
-0.07%
-1.50K
$6.05
-$9,075.00
2M
Sep 5 - Sep 8
No matching records found

Oncorus, Inc. (ONCR) Snapshot price: $0.126

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+2,360.18%
2.73M
$15.00
—
2.85M
Oct 6
Form 3
—
0
—
—
0
No matching records found